CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018 Oct 31, 2018
CohBar, Inc. to Announce 2018 Second Quarter Financial Results and Host Conference Call for Shareholders on August 14, 2018 Aug 2, 2018
CohBar Initiates Clinical Study with First-in-human Dosing of CB4211, a Novel Mitochondria Based Therapeutic for the Treatment of NASH Jul 12, 2018
CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions Jun 25, 2018
